Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Industrials | 8.98% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.27B
| $521K | ﹤0.01% |
6,800
+2,047
| +43% | +$160K |
|
2827
Avantis US Large Cap Value ETF
AVLV
$18.1B
| $521K | ﹤0.01% |
7,800
-13,000
| -63% | -$885K |
|
2828
Farmers National Banc Corp
FMNB
$947M
| $519K | ﹤0.01% |
36,484
-6,944
| -16% | -$103K |
|
2829
Invesco S&P 500 Revenue ETF
RWL
$9.85B
| $518K | ﹤0.01% |
5,289
-6,611
| -56% | -$662K |
|
2830
iShares MSCI France ETF
EWQ
$342M
| $517K | ﹤0.01% |
+14,400
| New | +$538K |
|
|
GHLD
2831
DELISTED
Guild Holdings
GHLD
| $516K | ﹤0.01% |
36,600
-6,800
| -16% | -$97.6K |
|
2832
Barnwell Industries
BRN
$14.7M
| $516K | ﹤0.01% |
341,863
-5,159
| -1% | -$9.41K |
|
2833
E.W. Scripps
SSP
$261M
| $515K | ﹤0.01% |
232,811
+20,128
| +9% | +$46.5K |
|
2834
Wave Life Sciences
WVE
$1.18B
| $514K | ﹤0.01% |
41,520
-63,000
| -60% | -$841K |
|
2835
SunPower Inc
SPWR
$60.2M
| $512K | ﹤0.01% |
+286,100
| New | +$580K |
|
|
CLPR
2836
Clipper Realty
CLPR
$44.8M
| $511K | ﹤0.01% |
111,657
-4,500
| -4% | -$25.3K |
|
|
BNT
2837
Brookfield Wealth Solutions
BNT
$12.3B
| $511K | ﹤0.01% |
13,350
+600
| +5% | +$22.6K |
|
2838
OneSpan
OSPN
$601M
| $511K | ﹤0.01% |
+27,570
| New | +$469K |
|
2839
Vanguard High Dividend Yield ETF
VYM
$82.6B
| $510K | ﹤0.01% |
4,000
-21,363
| -84% | -$2.79M |
|
2840
CVRx
CVRX
$146M
| $509K | ﹤0.01% |
+40,200
| New | +$496K |
|
2841
Fidelity D&D Bancorp
FDBC
$316M
| $503K | ﹤0.01% |
10,300
+300
| +3% | +$15.7K |
|
2842
Imperial Petroleum
IMPP
$208M
| $501K | ﹤0.01% |
166,500
+112,300
| +207% | +$385K |
|
2843
Terex
TEX
$7.55B
| $499K | ﹤0.01% |
10,800
-177,000
| -94% | -$9.23M |
|
2844
Capital Group International Focus Equity ETF
CGXU
$6.43B
| $498K | ﹤0.01% |
+20,200
| New | +$526K |
|
2845
GSI Technology
GSIT
$262M
| $498K | ﹤0.01% |
164,250
-41,500
| -20% | -$131K |
|
2846
Abeona Therapeutics
ABEO
$389M
| $497K | ﹤0.01% |
89,237
-45,041
| -34% | -$277K |
|
2847
Bank First Corp
BFC
$1.73B
| $495K | ﹤0.01% |
5,000
+200
| +4% | +$19.8K |
|
2848
State Street SPDR S&P Biotech ETF
XBI
$9.92B
| $495K | ﹤0.01% |
+5,500
| New | +$533K |
|
|
SY
2849
So-Young International
SY
$200M
| $495K | ﹤0.01% |
596,028
-19,500
| -3% | -$17.6K |
|
|
ZOM
2850
DELISTED
Zomedica Corp.
ZOM
| $494K | ﹤0.01% |
+4,120,642
| New | +$519K |
|
Similar funds
Renaissance Technologies's Q4 2024 Portfolio in Review
As of Q4 2024, Renaissance Technologies held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Renaissance Technologies added most to Alibaba in Q4 2024, an estimated $191M increase.
- Renaissance Technologies's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Renaissance Technologies fully exited Arm in Q4 2024, selling an estimated $153M.
- Renaissance Technologies's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Renaissance Technologies opened 548 new positions and closed 497 in Q4 2024.
- Renaissance Technologies's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.